The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Solid Formulations Drug Delivery Market Research Report 2025

Global Solid Formulations Drug Delivery Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1708787

No of Pages : 96

Ask Your Query
Synopsis
Solid Formulations are a solid body drug delivery system of various weights and shapes, adapted for introduction into orifices of the human body.4 The external membrane of the suppository will typically melt, soften, or dissolve at body temperature which allows the active ingredient to then be absorbed by the surrounding tissue. Suppository bases usually employed are cocoa butter, glycerinated gelatin, hydrogenated vegetable oils, mixtures of polyethylene glycols of various molecular weights, and fatty acid esters of polyethylene glycol. The suppository base employed has a marked influence on the release of the active ingredient incorporated in it.
The global Solid Formulations Drug Delivery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Solid Formulations Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Solid Formulations Drug Delivery.
Report Scope
The Solid Formulations Drug Delivery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Solid Formulations Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Solid Formulations Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Teva Pharmaceuticals
Bristol Myers Squibb
Lead Chemical
Purdue Pharma
Glenmark Pharmaceuticals
Galderma
Johnson & Johnson Private
GlaxoSmithKline
Bausch Health Companies
Hisamitsu Pharmaceuticals
Cipla
Bayer
Viatris
3M
Merck & Co
Crescita Therpeautics
Novartis International
Boehringer Ingelheim
Segment by Type
Powders
Suppositories
Segment by Application
Home Care Settings
Hospitals & Clinics
Burn Centers
Other Facilities
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Solid Formulations Drug Delivery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Solid Formulations Drug Delivery Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Powders
1.2.3 Suppositories
1.3 Market by Application
1.3.1 Global Solid Formulations Drug Delivery Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Home Care Settings
1.3.3 Hospitals & Clinics
1.3.4 Burn Centers
1.3.5 Other Facilities
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Solid Formulations Drug Delivery Market Perspective (2019-2030)
2.2 Solid Formulations Drug Delivery Growth Trends by Region
2.2.1 Global Solid Formulations Drug Delivery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Solid Formulations Drug Delivery Historic Market Size by Region (2019-2024)
2.2.3 Solid Formulations Drug Delivery Forecasted Market Size by Region (2025-2030)
2.3 Solid Formulations Drug Delivery Market Dynamics
2.3.1 Solid Formulations Drug Delivery Industry Trends
2.3.2 Solid Formulations Drug Delivery Market Drivers
2.3.3 Solid Formulations Drug Delivery Market Challenges
2.3.4 Solid Formulations Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Solid Formulations Drug Delivery Players by Revenue
3.1.1 Global Top Solid Formulations Drug Delivery Players by Revenue (2019-2024)
3.1.2 Global Solid Formulations Drug Delivery Revenue Market Share by Players (2019-2024)
3.2 Global Solid Formulations Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Solid Formulations Drug Delivery Revenue
3.4 Global Solid Formulations Drug Delivery Market Concentration Ratio
3.4.1 Global Solid Formulations Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Solid Formulations Drug Delivery Revenue in 2023
3.5 Solid Formulations Drug Delivery Key Players Head office and Area Served
3.6 Key Players Solid Formulations Drug Delivery Product Solution and Service
3.7 Date of Enter into Solid Formulations Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Solid Formulations Drug Delivery Breakdown Data by Type
4.1 Global Solid Formulations Drug Delivery Historic Market Size by Type (2019-2024)
4.2 Global Solid Formulations Drug Delivery Forecasted Market Size by Type (2025-2030)
5 Solid Formulations Drug Delivery Breakdown Data by Application
5.1 Global Solid Formulations Drug Delivery Historic Market Size by Application (2019-2024)
5.2 Global Solid Formulations Drug Delivery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Solid Formulations Drug Delivery Market Size (2019-2030)
6.2 North America Solid Formulations Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Solid Formulations Drug Delivery Market Size by Country (2019-2024)
6.4 North America Solid Formulations Drug Delivery Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Solid Formulations Drug Delivery Market Size (2019-2030)
7.2 Europe Solid Formulations Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Solid Formulations Drug Delivery Market Size by Country (2019-2024)
7.4 Europe Solid Formulations Drug Delivery Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Solid Formulations Drug Delivery Market Size (2019-2030)
8.2 Asia-Pacific Solid Formulations Drug Delivery Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Solid Formulations Drug Delivery Market Size by Region (2019-2024)
8.4 Asia-Pacific Solid Formulations Drug Delivery Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Solid Formulations Drug Delivery Market Size (2019-2030)
9.2 Latin America Solid Formulations Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Solid Formulations Drug Delivery Market Size by Country (2019-2024)
9.4 Latin America Solid Formulations Drug Delivery Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Solid Formulations Drug Delivery Market Size (2019-2030)
10.2 Middle East & Africa Solid Formulations Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Solid Formulations Drug Delivery Market Size by Country (2019-2024)
10.4 Middle East & Africa Solid Formulations Drug Delivery Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Solid Formulations Drug Delivery Introduction
11.1.4 Pfizer Revenue in Solid Formulations Drug Delivery Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 Teva Pharmaceuticals
11.2.1 Teva Pharmaceuticals Company Detail
11.2.2 Teva Pharmaceuticals Business Overview
11.2.3 Teva Pharmaceuticals Solid Formulations Drug Delivery Introduction
11.2.4 Teva Pharmaceuticals Revenue in Solid Formulations Drug Delivery Business (2019-2024)
11.2.5 Teva Pharmaceuticals Recent Development
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Company Detail
11.3.2 Bristol Myers Squibb Business Overview
11.3.3 Bristol Myers Squibb Solid Formulations Drug Delivery Introduction
11.3.4 Bristol Myers Squibb Revenue in Solid Formulations Drug Delivery Business (2019-2024)
11.3.5 Bristol Myers Squibb Recent Development
11.4 Lead Chemical
11.4.1 Lead Chemical Company Detail
11.4.2 Lead Chemical Business Overview
11.4.3 Lead Chemical Solid Formulations Drug Delivery Introduction
11.4.4 Lead Chemical Revenue in Solid Formulations Drug Delivery Business (2019-2024)
11.4.5 Lead Chemical Recent Development
11.5 Purdue Pharma
11.5.1 Purdue Pharma Company Detail
11.5.2 Purdue Pharma Business Overview
11.5.3 Purdue Pharma Solid Formulations Drug Delivery Introduction
11.5.4 Purdue Pharma Revenue in Solid Formulations Drug Delivery Business (2019-2024)
11.5.5 Purdue Pharma Recent Development
11.6 Glenmark Pharmaceuticals
11.6.1 Glenmark Pharmaceuticals Company Detail
11.6.2 Glenmark Pharmaceuticals Business Overview
11.6.3 Glenmark Pharmaceuticals Solid Formulations Drug Delivery Introduction
11.6.4 Glenmark Pharmaceuticals Revenue in Solid Formulations Drug Delivery Business (2019-2024)
11.6.5 Glenmark Pharmaceuticals Recent Development
11.7 Galderma
11.7.1 Galderma Company Detail
11.7.2 Galderma Business Overview
11.7.3 Galderma Solid Formulations Drug Delivery Introduction
11.7.4 Galderma Revenue in Solid Formulations Drug Delivery Business (2019-2024)
11.7.5 Galderma Recent Development
11.8 Johnson & Johnson Private
11.8.1 Johnson & Johnson Private Company Detail
11.8.2 Johnson & Johnson Private Business Overview
11.8.3 Johnson & Johnson Private Solid Formulations Drug Delivery Introduction
11.8.4 Johnson & Johnson Private Revenue in Solid Formulations Drug Delivery Business (2019-2024)
11.8.5 Johnson & Johnson Private Recent Development
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Detail
11.9.2 GlaxoSmithKline Business Overview
11.9.3 GlaxoSmithKline Solid Formulations Drug Delivery Introduction
11.9.4 GlaxoSmithKline Revenue in Solid Formulations Drug Delivery Business (2019-2024)
11.9.5 GlaxoSmithKline Recent Development
11.10 Bausch Health Companies
11.10.1 Bausch Health Companies Company Detail
11.10.2 Bausch Health Companies Business Overview
11.10.3 Bausch Health Companies Solid Formulations Drug Delivery Introduction
11.10.4 Bausch Health Companies Revenue in Solid Formulations Drug Delivery Business (2019-2024)
11.10.5 Bausch Health Companies Recent Development
11.11 Hisamitsu Pharmaceuticals
11.11.1 Hisamitsu Pharmaceuticals Company Detail
11.11.2 Hisamitsu Pharmaceuticals Business Overview
11.11.3 Hisamitsu Pharmaceuticals Solid Formulations Drug Delivery Introduction
11.11.4 Hisamitsu Pharmaceuticals Revenue in Solid Formulations Drug Delivery Business (2019-2024)
11.11.5 Hisamitsu Pharmaceuticals Recent Development
11.12 Cipla
11.12.1 Cipla Company Detail
11.12.2 Cipla Business Overview
11.12.3 Cipla Solid Formulations Drug Delivery Introduction
11.12.4 Cipla Revenue in Solid Formulations Drug Delivery Business (2019-2024)
11.12.5 Cipla Recent Development
11.13 Bayer
11.13.1 Bayer Company Detail
11.13.2 Bayer Business Overview
11.13.3 Bayer Solid Formulations Drug Delivery Introduction
11.13.4 Bayer Revenue in Solid Formulations Drug Delivery Business (2019-2024)
11.13.5 Bayer Recent Development
11.14 Viatris
11.14.1 Viatris Company Detail
11.14.2 Viatris Business Overview
11.14.3 Viatris Solid Formulations Drug Delivery Introduction
11.14.4 Viatris Revenue in Solid Formulations Drug Delivery Business (2019-2024)
11.14.5 Viatris Recent Development
11.15 3M
11.15.1 3M Company Detail
11.15.2 3M Business Overview
11.15.3 3M Solid Formulations Drug Delivery Introduction
11.15.4 3M Revenue in Solid Formulations Drug Delivery Business (2019-2024)
11.15.5 3M Recent Development
11.16 Merck & Co
11.16.1 Merck & Co Company Detail
11.16.2 Merck & Co Business Overview
11.16.3 Merck & Co Solid Formulations Drug Delivery Introduction
11.16.4 Merck & Co Revenue in Solid Formulations Drug Delivery Business (2019-2024)
11.16.5 Merck & Co Recent Development
11.17 Crescita Therpeautics
11.17.1 Crescita Therpeautics Company Detail
11.17.2 Crescita Therpeautics Business Overview
11.17.3 Crescita Therpeautics Solid Formulations Drug Delivery Introduction
11.17.4 Crescita Therpeautics Revenue in Solid Formulations Drug Delivery Business (2019-2024)
11.17.5 Crescita Therpeautics Recent Development
11.18 Novartis International
11.18.1 Novartis International Company Detail
11.18.2 Novartis International Business Overview
11.18.3 Novartis International Solid Formulations Drug Delivery Introduction
11.18.4 Novartis International Revenue in Solid Formulations Drug Delivery Business (2019-2024)
11.18.5 Novartis International Recent Development
11.19 Boehringer Ingelheim
11.19.1 Boehringer Ingelheim Company Detail
11.19.2 Boehringer Ingelheim Business Overview
11.19.3 Boehringer Ingelheim Solid Formulations Drug Delivery Introduction
11.19.4 Boehringer Ingelheim Revenue in Solid Formulations Drug Delivery Business (2019-2024)
11.19.5 Boehringer Ingelheim Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Solid Formulations Drug Delivery Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Powders
Table 3. Key Players of Suppositories
Table 4. Global Solid Formulations Drug Delivery Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Solid Formulations Drug Delivery Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Solid Formulations Drug Delivery Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Solid Formulations Drug Delivery Market Share by Region (2019-2024)
Table 8. Global Solid Formulations Drug Delivery Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Solid Formulations Drug Delivery Market Share by Region (2025-2030)
Table 10. Solid Formulations Drug Delivery Market Trends
Table 11. Solid Formulations Drug Delivery Market Drivers
Table 12. Solid Formulations Drug Delivery Market Challenges
Table 13. Solid Formulations Drug Delivery Market Restraints
Table 14. Global Solid Formulations Drug Delivery Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Solid Formulations Drug Delivery Market Share by Players (2019-2024)
Table 16. Global Top Solid Formulations Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Formulations Drug Delivery as of 2023)
Table 17. Ranking of Global Top Solid Formulations Drug Delivery Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Solid Formulations Drug Delivery Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Solid Formulations Drug Delivery Product Solution and Service
Table 21. Date of Enter into Solid Formulations Drug Delivery Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Solid Formulations Drug Delivery Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Solid Formulations Drug Delivery Revenue Market Share by Type (2019-2024)
Table 25. Global Solid Formulations Drug Delivery Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Solid Formulations Drug Delivery Revenue Market Share by Type (2025-2030)
Table 27. Global Solid Formulations Drug Delivery Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Solid Formulations Drug Delivery Revenue Market Share by Application (2019-2024)
Table 29. Global Solid Formulations Drug Delivery Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Solid Formulations Drug Delivery Revenue Market Share by Application (2025-2030)
Table 31. North America Solid Formulations Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Solid Formulations Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Solid Formulations Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Solid Formulations Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Solid Formulations Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Solid Formulations Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Solid Formulations Drug Delivery Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Solid Formulations Drug Delivery Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Solid Formulations Drug Delivery Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Solid Formulations Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Solid Formulations Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Solid Formulations Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Solid Formulations Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Solid Formulations Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Solid Formulations Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
Table 46. Pfizer Company Detail
Table 47. Pfizer Business Overview
Table 48. Pfizer Solid Formulations Drug Delivery Product
Table 49. Pfizer Revenue in Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. Teva Pharmaceuticals Company Detail
Table 52. Teva Pharmaceuticals Business Overview
Table 53. Teva Pharmaceuticals Solid Formulations Drug Delivery Product
Table 54. Teva Pharmaceuticals Revenue in Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 55. Teva Pharmaceuticals Recent Development
Table 56. Bristol Myers Squibb Company Detail
Table 57. Bristol Myers Squibb Business Overview
Table 58. Bristol Myers Squibb Solid Formulations Drug Delivery Product
Table 59. Bristol Myers Squibb Revenue in Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 60. Bristol Myers Squibb Recent Development
Table 61. Lead Chemical Company Detail
Table 62. Lead Chemical Business Overview
Table 63. Lead Chemical Solid Formulations Drug Delivery Product
Table 64. Lead Chemical Revenue in Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 65. Lead Chemical Recent Development
Table 66. Purdue Pharma Company Detail
Table 67. Purdue Pharma Business Overview
Table 68. Purdue Pharma Solid Formulations Drug Delivery Product
Table 69. Purdue Pharma Revenue in Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 70. Purdue Pharma Recent Development
Table 71. Glenmark Pharmaceuticals Company Detail
Table 72. Glenmark Pharmaceuticals Business Overview
Table 73. Glenmark Pharmaceuticals Solid Formulations Drug Delivery Product
Table 74. Glenmark Pharmaceuticals Revenue in Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 75. Glenmark Pharmaceuticals Recent Development
Table 76. Galderma Company Detail
Table 77. Galderma Business Overview
Table 78. Galderma Solid Formulations Drug Delivery Product
Table 79. Galderma Revenue in Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 80. Galderma Recent Development
Table 81. Johnson & Johnson Private Company Detail
Table 82. Johnson & Johnson Private Business Overview
Table 83. Johnson & Johnson Private Solid Formulations Drug Delivery Product
Table 84. Johnson & Johnson Private Revenue in Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 85. Johnson & Johnson Private Recent Development
Table 86. GlaxoSmithKline Company Detail
Table 87. GlaxoSmithKline Business Overview
Table 88. GlaxoSmithKline Solid Formulations Drug Delivery Product
Table 89. GlaxoSmithKline Revenue in Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 90. GlaxoSmithKline Recent Development
Table 91. Bausch Health Companies Company Detail
Table 92. Bausch Health Companies Business Overview
Table 93. Bausch Health Companies Solid Formulations Drug Delivery Product
Table 94. Bausch Health Companies Revenue in Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 95. Bausch Health Companies Recent Development
Table 96. Hisamitsu Pharmaceuticals Company Detail
Table 97. Hisamitsu Pharmaceuticals Business Overview
Table 98. Hisamitsu Pharmaceuticals Solid Formulations Drug Delivery Product
Table 99. Hisamitsu Pharmaceuticals Revenue in Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 100. Hisamitsu Pharmaceuticals Recent Development
Table 101. Cipla Company Detail
Table 102. Cipla Business Overview
Table 103. Cipla Solid Formulations Drug Delivery Product
Table 104. Cipla Revenue in Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 105. Cipla Recent Development
Table 106. Bayer Company Detail
Table 107. Bayer Business Overview
Table 108. Bayer Solid Formulations Drug Delivery Product
Table 109. Bayer Revenue in Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 110. Bayer Recent Development
Table 111. Viatris Company Detail
Table 112. Viatris Business Overview
Table 113. Viatris Solid Formulations Drug Delivery Product
Table 114. Viatris Revenue in Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 115. Viatris Recent Development
Table 116. 3M Company Detail
Table 117. 3M Business Overview
Table 118. 3M Solid Formulations Drug Delivery Product
Table 119. 3M Revenue in Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 120. 3M Recent Development
Table 121. Merck & Co Company Detail
Table 122. Merck & Co Business Overview
Table 123. Merck & Co Solid Formulations Drug Delivery Product
Table 124. Merck & Co Revenue in Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 125. Merck & Co Recent Development
Table 126. Crescita Therpeautics Company Detail
Table 127. Crescita Therpeautics Business Overview
Table 128. Crescita Therpeautics Solid Formulations Drug Delivery Product
Table 129. Crescita Therpeautics Revenue in Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 130. Crescita Therpeautics Recent Development
Table 131. Novartis International Company Detail
Table 132. Novartis International Business Overview
Table 133. Novartis International Solid Formulations Drug Delivery Product
Table 134. Novartis International Revenue in Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 135. Novartis International Recent Development
Table 136. Boehringer Ingelheim Company Detail
Table 137. Boehringer Ingelheim Business Overview
Table 138. Boehringer Ingelheim Solid Formulations Drug Delivery Product
Table 139. Boehringer Ingelheim Revenue in Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 140. Boehringer Ingelheim Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Solid Formulations Drug Delivery Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Solid Formulations Drug Delivery Market Share by Type: 2023 VS 2030
Figure 3. Powders Features
Figure 4. Suppositories Features
Figure 5. Global Solid Formulations Drug Delivery Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Solid Formulations Drug Delivery Market Share by Application: 2023 VS 2030
Figure 7. Home Care Settings Case Studies
Figure 8. Hospitals & Clinics Case Studies
Figure 9. Burn Centers Case Studies
Figure 10. Other Facilities Case Studies
Figure 11. Solid Formulations Drug Delivery Report Years Considered
Figure 12. Global Solid Formulations Drug Delivery Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Solid Formulations Drug Delivery Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Solid Formulations Drug Delivery Market Share by Region: 2023 VS 2030
Figure 15. Global Solid Formulations Drug Delivery Market Share by Players in 2023
Figure 16. Global Top Solid Formulations Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Formulations Drug Delivery as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Solid Formulations Drug Delivery Revenue in 2023
Figure 18. North America Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Solid Formulations Drug Delivery Market Share by Country (2019-2030)
Figure 20. United States Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Solid Formulations Drug Delivery Market Share by Country (2019-2030)
Figure 24. Germany Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Solid Formulations Drug Delivery Market Share by Region (2019-2030)
Figure 32. China Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Solid Formulations Drug Delivery Market Share by Country (2019-2030)
Figure 40. Mexico Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Solid Formulations Drug Delivery Market Share by Country (2019-2030)
Figure 44. Turkey Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Pfizer Revenue Growth Rate in Solid Formulations Drug Delivery Business (2019-2024)
Figure 47. Teva Pharmaceuticals Revenue Growth Rate in Solid Formulations Drug Delivery Business (2019-2024)
Figure 48. Bristol Myers Squibb Revenue Growth Rate in Solid Formulations Drug Delivery Business (2019-2024)
Figure 49. Lead Chemical Revenue Growth Rate in Solid Formulations Drug Delivery Business (2019-2024)
Figure 50. Purdue Pharma Revenue Growth Rate in Solid Formulations Drug Delivery Business (2019-2024)
Figure 51. Glenmark Pharmaceuticals Revenue Growth Rate in Solid Formulations Drug Delivery Business (2019-2024)
Figure 52. Galderma Revenue Growth Rate in Solid Formulations Drug Delivery Business (2019-2024)
Figure 53. Johnson & Johnson Private Revenue Growth Rate in Solid Formulations Drug Delivery Business (2019-2024)
Figure 54. GlaxoSmithKline Revenue Growth Rate in Solid Formulations Drug Delivery Business (2019-2024)
Figure 55. Bausch Health Companies Revenue Growth Rate in Solid Formulations Drug Delivery Business (2019-2024)
Figure 56. Hisamitsu Pharmaceuticals Revenue Growth Rate in Solid Formulations Drug Delivery Business (2019-2024)
Figure 57. Cipla Revenue Growth Rate in Solid Formulations Drug Delivery Business (2019-2024)
Figure 58. Bayer Revenue Growth Rate in Solid Formulations Drug Delivery Business (2019-2024)
Figure 59. Viatris Revenue Growth Rate in Solid Formulations Drug Delivery Business (2019-2024)
Figure 60. 3M Revenue Growth Rate in Solid Formulations Drug Delivery Business (2019-2024)
Figure 61. Merck & Co Revenue Growth Rate in Solid Formulations Drug Delivery Business (2019-2024)
Figure 62. Crescita Therpeautics Revenue Growth Rate in Solid Formulations Drug Delivery Business (2019-2024)
Figure 63. Novartis International Revenue Growth Rate in Solid Formulations Drug Delivery Business (2019-2024)
Figure 64. Boehringer Ingelheim Revenue Growth Rate in Solid Formulations Drug Delivery Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock